VBIV - VBI Vaccines Inc.
Previous close
0.0653
0 0%
Share volume: 294,352
Last Updated: Wed 07 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-09 | 2022-08-08 | 2022-11-10 | 2023-03-13 | 2023-05-15 | 2023-08-14 | 2023-11-14 | |
| Assets | ||||||||
| Total Assets | 194.006 M | 172.161 M | 172.010 M | 155.086 M | 128.461 M | 88.322 M | 100.784 M | |
| Current Assets | 112.347 M | 92.752 M | 96.216 M | 77.690 M | 51.836 M | 31.891 M | 50.147 M | |
| Inventories | 4.057 M | 4.050 M | 5.796 M | 6.599 M | 6.768 M | 6.861 M | 7.540 M | |
| Other Current Assets | 4.082 M | 3.840 M | 4.388 M | 4.335 M | 4.395 M | 4.111 M | 3.330 M | |
| Short Term Investments | 4.082 M | 3.840 M | 4.388 M | 4.335 M | 4.395 M | 4.111 M | 3.330 M | |
| Total Receivables | 2.871 M | 2.448 M | 2.482 M | 4.127 M | 281.000 K | 79.000 K | 3.823 M | |
| Current Cash | 101.337 M | 82.414 M | 83.550 M | 62.629 M | 40.392 M | 20.840 M | 35.454 M | |
| Total Non-current Assets | 81.659 M | 79.409 M | 75.794 M | 77.396 M | 76.625 M | 56.431 M | 50.637 M | |
| Property Plant Equipment | 10.846 M | 11.015 M | 11.149 M | 12.253 M | 11.690 M | 10.104 M | 9.423 M | |
| Other Assets | 1.446 M | 1.396 M | 1.349 M | 1.355 M | 1.311 M | 1.110 M | 1.094 M | |
| Intangible Assets | 63.218 M | 61.379 M | 57.727 M | 58.345 M | 58.500 M | 40.339 M | 35.603 M | |
| Goodwill | 2.303 M | 2.237 M | 2.104 M | 2.127 M | 2.132 M | 2.175 M | 2.121 M | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 194.006 M | 172.161 M | 172.010 M | 155.086 M | 128.461 M | 88.322 M | 100.784 M | |
| Total liabilities | 64.442 M | 66.603 M | 88.193 M | 90.923 M | 83.439 M | 79.584 M | 80.898 M | |
| Total current liabilities | 33.991 M | 40.532 M | 34.681 M | 36.942 M | 29.573 M | 27.674 M | 77.194 M | |
| Accounts Payable | 3.927 M | 5.617 M | 11.666 M | 12.973 M | 9.837 M | 7.353 M | 7.008 M | |
| Other liabilities | 2.742 M | 2.401 M | 2.523 M | 2.728 M | 2.481 M | 2.339 M | 2.278 M | |
| Current long term debt | 4.744 M | 8.780 M | 0.000 | 0.000 | 0.000 | 1.990 M | 50.299 M | |
| Long term debt | 24.788 M | 21.163 M | 48.418 M | 48.888 M | 49.359 M | 47.839 M | 0.000 | |
| Other liabilities | 2.742 M | 2.401 M | 2.523 M | 2.728 M | 2.481 M | 2.339 M | 2.278 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 129.564 M | 105.558 M | 83.817 M | 64.163 M | 45.022 M | 8.738 M | 19.886 M | |
| Common stock | 258.257 M | 258.257 M | 258.257 M | 258.258 M | 8.609 M | 8.609 M | 21.167 M | |
| Retained earnings | -397.560 M | -443.259 M | -468.468 M | -489.609 M | -517.360 M | -561.988 M | -582.432 M |